Phaseline

Companies › Heron Neutron Medical

Heron Neutron Medical: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Oncology; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
F18 FBPA
Radiolabeled phenylalanine analog with uptake facilitated by L-type amino acid transporter
SLC7A5Phase 1Solid TumorDec 2026

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07691775F18 FBPAPhase 1Solid TumorOncologyDec 2026

Targets

SLC7A5 (1)

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.